Bekes Varmegyei Koezponti Korhaz

At Bekes Varmegyei Koezponti Korhaz in Gyula, a major share of research focuses on respiratory tract diseases and neoplasms, especially non-small cell lung cancer and related advanced lung tumors. These studies are designed to test new treatment approaches, compare them with current standards, and improve survival outcomes for people with difficult-to-treat cancers.

• Non-small cell lung cancer and advanced lung cancer
• Stage IV, metastatic, and PD-L1–positive disease
• Evaluating new cancer therapies and combinations against established care

The site’s pulmonary department supports a broad oncology portfolio, with research aimed at better disease control, longer progression-free survival, and improved overall outcomes.

The clinical trial program includes extensive work in breast cancer and prostate cancer, covering both early and advanced disease. Studies are exploring new endocrine-based strategies, targeted treatments, and combination approaches to reduce recurrence and improve disease control in hormone-driven cancers.

• ER-positive, HER2-negative breast cancer
• Metastatic breast cancer and high-risk early-stage disease
• Prostate cancer, including metastatic castration-resistant and high-risk localized disease

Research at the site includes efforts to prevent recurrence, delay progression, and identify more effective options for patients whose cancer has returned or spread.

A strong portion of the research landscape centers on immune system diseases and chronic inflammatory conditions such as systemic lupus erythematosus, psoriatic arthritis, rheumatoid arthritis, and Sjögren’s syndrome. These trials are mainly aimed at improving symptom control, reducing disease activity, and assessing the long-term safety of newer immune-modulating treatments.

• Systemic lupus erythematosus and related systemic autoimmune disease
• Psoriatic arthritis and rheumatoid arthritis
• Sjögren’s syndrome and other immune-mediated disorders

This area reflects a broad interest in therapies that may help patients live with fewer flares, less inflammation, and better daily function.

The site also conducts research in cardiovascular diseases and nutritional and metabolic diseases, including heart failure, acute myocardial infarction, hyperlipidaemia, and type 2 diabetes. These studies are focused on lowering cardiovascular risk, improving heart function, and testing whether newer therapies can better support long-term prevention and treatment.

• Heart failure and inflammation-related cardiac disease
• Acute myocardial infarction and prevention of recurrent events
• Hyperlipidaemia and type 2 diabetes

Research in this field aims to reduce serious complications such as heart attack, stroke, and worsening heart failure while improving everyday disease management.

Clinical trials at the hospital cover bacterial infections, virus diseases, and selected digestive system diseases, including chronic hepatitis B and primary biliary cholangitis. There is also work on preventing surgical infections and supporting safer care around urgent procedures.

• Chronic hepatitis B and liver-related disease
• Post-surgical infection prevention
• Bacterial pneumonia and other serious infections

These studies are intended to improve infection control, support recovery after surgery, and explore better options for chronic liver conditions with ongoing symptoms.

Beyond the main specialty areas, Bekes Varmegyei Koezponti Korhaz participates in trials across a wide range of chronic conditions, including chronic obstructive pulmonary disease, chronic kidney disease, pruritus, and selected mental disorders in children and adolescents. The aim is often to improve symptom relief, strengthen disease control, or assess whether new therapies can offer better everyday outcomes.

• COPD and other chronic respiratory conditions
• Chronic kidney disease and multisystem inflammatory disease
• Pruritus and symptom-driven quality-of-life research

This mix of studies shows a broad clinical research profile that extends beyond one specialty, with attention to both complex diseases and patient-reported symptoms.